Nu Skin Enterprises, Inc. (NUS) Fair Value 2026

NUS · Household & Personal Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.7 /10

32 fundamental signals · 9 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-08-27, Nu Skin Enterprises, Inc. (NUS) trades at $4.79, versus a $12.66 median fair value across its 9 active models — 164.4% above the current price. QOC: 7.7/10. Value Trap Risk: 19/100 (SAFE). 9/13 models active. Within that set, the Bayesian DCF component alone returns $12.66.

Key Facts

Ticker
NUS
Price
$4.79
Quality Score
7.7/10
Value Trap Risk
19/100
Models Active
9/13
Last Updated
Strength: CUCE Ensemble suggests +243.0% upside with 8% confidence
Risk: Limited model coverage (9/13) may reduce confidence

Is Nu Skin Enterprises, Inc. (NUS) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, Nu Skin Enterprises, Inc. (NUS) appears undervalued as of : the median of 9 independent fair value estimates is $12.66, 164.4% above the current price of $4.79. Estimates range from $0.07 to $27.71. NUS scores 7.7/10 on fundamental quality and 19/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. NUS’s +164.4% gap is wider than that market norm, and the Household & Personal Products sector median is -6.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Nu Skin Enterprises, Inc. Stock in 2026? →

What Fair Value Does Each Model Give NUS?

9 Intrinsic Value Models vs. Current Price ($4.79)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $12.66 +164.4%
Intrinsic · High Conviction
 $3.54 -26.2%
Ensemble · Low Conviction
 $16.43 +243.0%
Intrinsic · High Conviction
 $3.12 -34.9%
Unlock the Full Matrix

Access 5 additional models including EROIC Spread, Dynamic NAV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is NUS's Fair Value Range?

Spread across 9 independent models · $0.07 to $27.71

CirclFi's 9 active models place Nu Skin Enterprises, Inc. (NUS) between $0.07 and $27.71 per share, a spread of 218% of the median. The median of that range — $12.66 — is the fair value CirclFi publishes for NUS, against a current price of $4.79.

Low · EROICHigh · Sentiment SOTP
$0.07median $12.66$27.71
Where the range comes from
Most bearish modelEROIC Spread$0.07
Most bullish modelSentiment SOTP$27.71
Model agreement5 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for NUS. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on NUS, not a CirclFi price target. How each model works →

What Is Nu Skin Enterprises, Inc. (NUS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Nu Skin Enterprises, Inc. at $4.79. With an estimated intrinsic value of $12.66 and 5 of 9 models pointing higher, the median implied return is +164.4%. The most optimistic model, Sentiment SOTP, places fair value at $27.71 (+478.5%), while EROIC — the most conservative — estimates $0.07 (-98.6%). This +577.0% gap reflects genuine analytical uncertainty about Nu Skin Enterprises, Inc.'s intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About NUS?

9 of 13 models are currently active for NUS. Of these, 5 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for NUS is $12.66 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $12.66 on its own, implying +164.4% upside from the current price. See which stocks rank higher →

How Does NUS Rank in Household & Personal Products?

Among 35 Household & Personal Products stocks, NUS ranks #10 by Quality of Company score. CirclFi's QOC score of 7.7/10 evaluates 32 fundamental signals. A score of 7.7 indicates above-average quality.

The Household & Personal Products sector introduces analytical considerations specific to consumer businesses. For Nu Skin Enterprises, Inc., metrics like inventory turnover provide important context that general-purpose valuation models may underweight.

Is NUS a Value Trap?

CirclFi's Value Trap algorithm assigns NUS a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for Nu Skin Enterprises, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Nu Skin Enterprises, Inc. earns a quality score of 7.7/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +577.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NUS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NUS's 9 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Nu Skin Enterprises, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Household & Personal Products Stocks Should You Also Analyze?

10 related Household & Personal Products stocks with 13-model coverage

CLXThe Clorox CompanyQOC 7.9SPBSpectrum Brands Holdings, Inc.QOC 7.7KMBKimberly-Clark CorporationQOC 8.0ULUnilever PLCQOC 7.6UGUnited-Guardian, Inc.QOC 8.1KVUEKenvue Inc.QOC 7.6RAYRaytech Holding LimitedQOC 6.8WALDWaldencast plcQOC 5.7IPARInterparfums, Inc.QOC 9.3PGThe Procter & Gamble CompanyQOC 8.8

Read investment analysis: CLX · SPB · KMB · UL · UG · KVUE · RAY · WALD · IPAR · PG

Which Other Stocks Have a Similar Quality Score to NUS?

6 companies across all industries closest to NUS’s Quality of Company score of 7.7/10.

CMCCommercial Metals CompanyQOC 7.7MOHMolina Healthcare, Inc.QOC 7.7MSEXMiddlesex Water CompanyQOC 7.7KRGKite Realty Group TrustQOC 7.7VSNTVersant Media Group, Inc.QOC 7.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CMC · MOH · MSEX · KRG · VSNT · NVDA

What Else Do Investors Ask About Nu Skin Enterprises, Inc.’s Valuation?

What is Nu Skin Enterprises, Inc.'s intrinsic value in 2026?

CirclFi puts Nu Skin Enterprises, Inc. (NUS)'s intrinsic value at $12.66 — the median of 9 independent model estimates as of 2026-08-27, ranging from $0.07 to $27.71. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $12.66 on its own. The Quality of Company score is 7.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NUS overvalued or undervalued right now?

At $4.79, 5 of 9 active models suggest NUS may be undervalued, while 4 indicate potential overvaluation. The median of all 9 fair value estimates is $12.66, 164.4% above the current price of $4.79 — a consensus view that NUS is undervalued. The assessment depends on which methodology best fits Nu Skin Enterprises, Inc.'s business model in Household & Personal Products.

What does a Quality of Company score of 7.7 mean for NUS?

Nu Skin Enterprises, Inc.'s QOC of 7.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on NUS?

CirclFi analyzes NUS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on NUS?

Of the 9 models currently active on NUS, Sentiment SOTP is the most bullish at $27.71 per share, and EROIC Spread is the most bearish at $0.07. CirclFi's published fair value for NUS is the median of that range, $12.66, not either extreme. The gap between the two ends equals 218% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is NUS a value trap in 2026?

Nu Skin Enterprises, Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, Nu Skin Enterprises, Inc. (NUS) has a median fair value of $12.66 — 164.4% above the current price of $4.79 — as of 2026-08-27.” Source: circlfi.com/stock/NUS/ · Methodology
Primary sources for this NUS valuation
  • Financial statements: Nu Skin Enterprises, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001021561) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for NUS as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on NUS.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for NUS Unlock All 9 — $39/mo